Job & Funding Opportunities – w/c 6th June 2022
NHS Scotland Innovation Fellowship Scheme This award provides funding for [...]
Research Updates – W/C 06/06/2022
Transforming the drug market to a health and human rights [...]
Industry News – W/C 06/06/2022
The UK’s first regular drug checking service The UK’s first [...]
Event report: IOTOD Conference 11-12 May 2022
Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) is [...]
Research Updates – W/C 09/05/2022
Police officers’ perceptions of their role at overdose events A [...]
Psychedelic-assisted therapy – an information session
An event report from a session run by Dr J. [...]
Industry News – W/C 09/05/2022
Life with Alcohol and Drugs Podcast The next episode of [...]
Effective Service Evaluation: An introduction session for third sector organisations
On the 10th June, 9:30am-12:30pm, DRNS will be supporting Evaluation [...]
The Prescription Opioid Overdose Risk 1 (POOR1) study: Developing a bespoke overdose prevention intervention for people who are prescribed high-strength opioids for chronic non-cancer pain GalleryThe Prescription Opioid Overdose Risk 1 (POOR1) study: Developing a bespoke overdose prevention intervention for people who are prescribed high-strength opioids for chronic non-cancer pain
The Prescription Opioid Overdose Risk 1 (POOR1) study: Developing a bespoke overdose prevention intervention for people who are prescribed high-strength opioids for chronic non-cancer pain
Introduction This is the first of a two-part series that [...]
Chatting with Professor Richard Velleman – Part Two
Part two: Conferences and The Addiction and the Family International [...]
